HBC Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
HBC Financial Services's PFE Position: Q4 2024 in Review
HBC Financial Services held its Pfizer (PFE) position steady in Q4 2024 at 150 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #153.
HBC Financial Services first reported a position in PFE in Q4 2019 and has held it in 21 quarters since. The position peaked at $63K in Q4 2019. 3,001 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- HBC Financial Services held 150 shares of Pfizer worth $3K as of Q4 2024.
- HBC Financial Services left its Pfizer share count unchanged in Q4 2024.
- Pfizer made up ﹤0.01% of HBC Financial Services's portfolio in Q4 2024, its #153 holding.
- HBC Financial Services first reported a position in Pfizer in Q4 2019 and has held it in 21 quarters since.
- HBC Financial Services's Pfizer position peaked at $63K in Q4 2019.
- 3,001 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on HBC Financial Services's 13F filing for Q4 2024, filed 16 Jan 2025.